UmanDiagnostics Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 10

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $21.2M

UmanDiagnostics General Information

Description

Developer of a biopharmaceutical product designed to deliver an accurate diagnosis of neurological diseases. The company's product allows fast quantification of neurofilament light in cerebrospinal fluid for direct measurement of NF-L in many different neurological conditions, enabling healthcare professionals and doctors to easiy detect neurological and traumatic injuries in the brain.

Contact Information

Website
www.umandiagnostics.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Parent Company
Quanterix
Primary Office
  • Tvistevägen 48 C
  • 907 36 Umea
  • Sweden
+46 090-77 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

UmanDiagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 01-Aug-2019 $21.2M 000.00 Completed Generating Revenue
2. Early Stage VC 12-Apr-2006 Completed Startup
1. Accelerator/Incubator Completed Startup
To view UmanDiagnostics’s complete valuation and funding history, request access »

UmanDiagnostics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biopharmaceutical product designed to deliver an accurate diagnosis of neurological diseases. The company
Diagnostic Equipment
Umea, Sweden
10 As of 2022
00.00 0000-00-00
000000&0

00000

tur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna
0000000000000
San Diego, CA
00 As of 0000
000.00
00000000000 000.00

000000

exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute
0000000000 000000000
Sunnyvale, CA
0000 As of 0000
000.00
0000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

UmanDiagnostics Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aviva Systems Biology Formerly VC-backed San Diego, CA 00 000.00 00000000000 000.00
0000000 Formerly VC-backed Sunnyvale, CA 0000 000.00 0000000000
000000000 Formerly VC-backed Milpitas, CA 00 000000&0
You’re viewing 3 of 3 competitors. Get the full list »

UmanDiagnostics Executive Team (1)

Name Title Board Seat Contact Info
Niklas Norgren Ph.D Co-Founder, Chief Executive Officer & Vice President
To view UmanDiagnostics’s complete executive team members history, request access »

UmanDiagnostics Board Members (2)

Name Representing Role Since
Bo Hammarström Self Board Member 000 0000
Torgny Stigbrand UmanDiagnostics Board Member 000 0000
To view UmanDiagnostics’s complete board members history, request access »

UmanDiagnostics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

UmanDiagnostics Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Innovationsbron Venture Capital Minority 000 0000 000000 0
Inro Biomedtek Corporation Minority 000 0000 000000 0
Norrlandsfonden Lender/Debt Provider Minority 000 0000 000000 0
Umeå Biotech Incubator Accelerator/Incubator Minority 000 0000 000000 0
Uminova Invest Venture Capital Minority 000 0000 000000 0
To view UmanDiagnostics’s complete investors history, request access »

Ready to get started?

Request a free trial